Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men.
To establish whether somatostatin (SRIH) and/or endogenous opioids play a role in the control of arginine-vasopressin (AVP) response to physical exercise, eight healthy men underwent four bicycle-ergometer tests until exhaustion: exercise control test; exercise plus SRIH, naloxone or SRIH plus naloxone. Serum AVP levels, physiological and biochemical variables were measured during tests. Physiological and biochemical variables were similar in all tests. During control test exercise significantly increased serum AVP levels, with a peak value 4.1 times higher than baseline. The AVP response to exercise was similar in the presence of naloxone, whereas it was significantly reduced by SRIH (AVP peak was only 2.8 times higher than baseline). When SRIH and naloxone were given together, the exercise-induced AVP rise was comparable to that observed in the control test. Results indicate a somatostatinergic involvement in the regulation of the AVP response to physical exercise. Furthermore, naloxone-sensitive endogenous opioids appear to play a role in the mechanism underlying SRIH inhibitory action, but not in mediation of the AVP response to physical exercise.
Coiro
V
V
Department of Internal Medicine and Biomedical Sciences, University of Parma, Parma, Italy. vittorio.coiro@unipr.it
Casti
A
A
Rubino
P
P
Manfredi
G
G
Maffei
M L
ML
Volta
E
E
Cataldo
S
S
Melani
A
A
Saccani Jotti
G
G
Chiodera
P
P
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood*; D001786:Blood Glucose / Q000187:drug effects; D004347:Drug Interactions / Q000502:physiology; D015444:Exercise / Q000502:physiology*; D005080:Exercise Test; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology; D018847:Opioid Peptides / Q000037:antagonists & inhibitors; D009994:Osmolar Concentration; D010809:Physical Fitness / Q000502:physiology*; D013004:Somatostatin / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
D001786:Blood Glucose; D009292:Narcotic Antagonists; D018847:Opioid Peptides; D001127:Arginine Vasopressin; D009270:Naloxone; D013004:Somatostatin